These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8283158)

  • 1. The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up.
    Heinonen OP; Huttunen JK; Manninen V; Mänttäri M; Koskinen P; Tenkanen L; Frick MH
    J Intern Med; 1994 Jan; 235(1):41-9. PubMed ID: 8283158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.
    Huttunen JK; Heinonen OP; Manninen V; Koskinen P; Hakulinen T; Teppo L; Mänttäri M; Frick MH
    J Intern Med; 1994 Jan; 235(1):31-9. PubMed ID: 8283157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemfibrozil in the treatment of dyslipidemia: an 18-year mortality follow-up of the Helsinki Heart Study.
    Tenkanen L; Mänttäri M; Kovanen PT; Virkkunen H; Manninen V
    Arch Intern Med; 2006 Apr; 166(7):743-8. PubMed ID: 16606810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.
    Koskinen P; Mänttäri M; Manninen V; Huttunen JK; Heinonen OP; Frick MH
    Diabetes Care; 1992 Jul; 15(7):820-5. PubMed ID: 1516498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.
    Frick MH; Heinonen OP; Huttunen JK; Koskinen P; Mänttäri M; Manninen V
    Ann Med; 1993 Feb; 25(1):41-5. PubMed ID: 8435186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study.
    Manninen V; Huttunen JK; Heinonen OP; Tenkanen L; Frick MH
    Am J Cardiol; 1989 May; 63(16):42H-47H. PubMed ID: 2650524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
    Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
    Robins SJ; Collins D; Wittes JT; Papademetriou V; Deedwania PC; Schaefer EJ; McNamara JR; Kashyap ML; Hershman JM; Wexler LF; Rubins HB;
    JAMA; 2001 Mar; 285(12):1585-91. PubMed ID: 11268266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol and coronary heart disease: the roles of HDL-cholesterol and smoking.
    Mänttäri M; Tenkanen L; Alikoski T; Manninen V
    J Intern Med; 1997 Feb; 241(2):157-63. PubMed ID: 9077373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
    N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helsinki Heart Study. New perspectives in the prevention of coronary heart disease.
    Huttunen JK; Frick MH; Heinonen OP; Heinsalmi P; Manninen V; Mänttäri M; Romo M
    Drugs; 1988; 36 Suppl 3():32-6. PubMed ID: 3076118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoproteins and coronary heart disease in the Helsinki Heart Study.
    Mänttäri M; Huttunen JK; Koskinen P; Manninen V; Tenkanen L; Heinonen OP; Frick MH
    Eur Heart J; 1990 Dec; 11 Suppl H():26-31. PubMed ID: 2073911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease.
    Hay JW; Sterling KL
    Pharmacoeconomics; 2005; 23(2):133-41. PubMed ID: 15748088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil cost-benefit study. Targeting subgroups for effective hyperlipidaemia drug therapy.
    Sarma S; Fifer SK
    Drugs; 1990; 40 Suppl 1():42-52. PubMed ID: 2127008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body weight, plasma insulin, and coronary events with gemfibrozil in the Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT).
    Robins SJ; Collins D; McNamara JR; Bloomfield HE
    Atherosclerosis; 2008 Feb; 196(2):849-55. PubMed ID: 17335828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of gemfibrozil in the primary prevention of atrial fibrillation in a large randomized controlled trial.
    Adabag AS; Mithani S; Al Aloul B; Collins D; Bertog S; Bloomfield HE;
    Am Heart J; 2009 May; 157(5):913-8. PubMed ID: 19376321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Helsinki Heart Study: basic design and randomization procedure.
    Mänttäri M; Elo O; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    Eur Heart J; 1987 Oct; 8 Suppl I():1-29. PubMed ID: 3322826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.